Replimune's drug for advanced skin cancer fails to win FDA nod again
(()=>{"use strict";window.initData=window.initData||{},window.initData.block_widgetbar=function(i,t,a,n){function e(a){const e={resizerBridge:t.allocate({areaName:"right"}),affectsLayout:()=>!0,adapti
tradingview.com•April 12, 2026